Rozerem

• Generic Name: ramelteon
• Brand Name: Rozerem
• Drug Class: , Melatonin Receptor Agonists

Rozerem (Ramelteon) side effects drug center

• Related Drugs
  Ambien Ambien CR Belsomra Dalmane Dayvigo Doral Edluar Intermezzo Lunesta Restoril Seconal Sodium Silenor Sonata Zolpimist
• Health Resources
  Insomnia Insomnia Treatment (Sleep Aids and Stimulants) Sleep Disorders (How to Get a Good Night's Sleep)
• Related Supplements
  Lemon Balm Melatonin Tyrosine Valerian
• Drug Comparison
  Ambien vs. Rozerem Lunesta vs. Rozerem
• Rozerem User Reviews

 

PROFESSIONAL

CONSUMER

SIDE EFFECTS

• Overview
• Consumer Information
• Professional Information

 

Rozerem Side Effects Center

What Is Rozerem?

Rozerem (ramelteon) is a hypnotic type sedative used to treat insomnia that is associated with having trouble falling asleep. Unlike some other sleep medications, Rozerem is not known to be habit-forming.

What Are Side Effects of Rozerem?

Common side effects of Rozerem include:

• dizziness,
• tiredness,
• daytime drowsiness,
• nausea, or
• worsening sleep problems.

Tell your doctor if you have unlikely but serious side effects of Rozerem including:

• decreased sexual desire,
• missed menstrual periods,
• nipple discharge, or
• difficulty becoming pregnant.

Dosage for Rozerem

The recommended dose of Rozerem is 8 mg taken within 30 minutes of going to bed.

What Drugs, Substances, or Supplements Interact with Rozerem?

Rozerem may interact with primaquine, thabendazole, rifampin, antibiotics, heart rhythm medications, or antifungal medications. Tell your doctor all medications you are taking.

Rozerem During Pregnancy or Breastfeeding

Rozerem should be used only when prescribed during pregnancy. It is unknown if this drug passes into breast milk and the effect on a nursing infant is unknown. Consult your doctor before breastfeeding.

Additional Information

Our Rozerem (ramelteon) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

 

Rozerem Consumer Information

Ramelteon may cause a severe allergic reaction. Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; nausea and vomiting; swelling of your face, lips, tongue, or throat.

Some people using this medicine have engaged in activity while not fully awake and later had no memory of it. This may include walking, driving, eating, having sex, or making phone calls. If this happens to you, call your doctor right away.

Call your doctor at once if you have:

• unusual thoughts or behavior, hallucinations, worsening depression, thoughts about hurting yourself;
• a missed menstrual period;
• nipple discharge; or
• loss of interest in sex.

Common side effects may include:

• drowsiness, tired feeling;
• dizziness;
• nausea; or
• worsening sleep problems.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Rozerem (Ramelteon)

 

Rozerem Professional Information

SIDE EFFECTS

The following serious adverse reactions are discussed in greater detail in other sections:

• Severe anaphylactic and anaphylactoid reactions [see WARNINGS AND PRECAUTIONS]
• Abnormal thinking, behavior changes, and complex behaviors [see WARNINGS AND PRECAUTIONS]
• CNS effects [see WARNINGS AND PRECAUTIONS]

Clinical Trials Experience

Adverse Reactions Resulting In Discontinuation Of Treatment

The data described in this section reflect exposure to ROZEREM in 5373 subjects, including 722 exposed for six months or longer, and 448 subjects for one year.

Six percent of the 5373 individual subjects exposed to ROZEREM in clinical studies discontinued treatment owing to an adverse event, compared with 2% of the 2279 subjects receiving placebo.

The most frequent adverse events leading to discontinuation in subjects receiving ROZEREM were somnolence, dizziness, nausea, fatigue, headache, and insomnia; all of which occurred in 1% of the patients or less.

Rozerem Most Commonly Observed Adverse Events

Table 1 displays the incidence of adverse events reported by the 2861 patients with chronic insomnia who participated in placebo-controlled trials of ROZEREM.

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in clinical trials of other drugs, and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to drug use and for approximating rates.

Table 1. Incidence (% of subjects) of Treatment-Emergent Adverse Events

MedDRA Preferred Term	Placebo (n=1456)	Ramelteon 8 mg (n=1405)
Somnolence	2%	3%
Fatigue	2%	3%
Dizziness	3%	4%
Nausea	2%	3%
Insomnia exacerbated	2%	3%

Read the entire FDA prescribing information for Rozerem (Ramelteon)

&Copy; Rozerem Patient Information is supplied by Cerner Multum, Inc. and Rozerem Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.